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ABSTRACT
This is a case report discussing the case of a patient with fungal infection after undergoing a descemet stripping 
automated endothelial keratoplasty (DSAEK). The pathogenesis and possible treatment options of fungal keratitis 
are discussed. Also, the precautions that should be taken in order to prevent fungal keratitis in patients undergoing 
DSAEK are referred to.
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INTRODUCTION
Fungal keratitis is an infection of the cornea 
caused by any of the multiple pathologic fungi ca-
pable of contaminating human beings. The progres-
sion [1, 2] is typically slow and it should be differen-
tiated from other types of corneal infections, espe-
cially from bacterial ones, because they present with 
similar symptoms and clinical image. Some of the 
fungi1 that can affect the cornea are Candida spp., 
Aspergillus spp., Fusarium spp., Cladosporium spp., 
Curvularia, and Rhizopus.
Some of the risk factors [3–6] for a fungal kerati-
tis outbreak are: trauma, ocular surface disease, ocu-
lar surgery, and topical steroid use. Also, in warmer 
and more humid environments, fungal keratitis is 
more likely to manifest. Fungal keratitis [4, 5] can 
also be associated with contact lens misuse. The 
infection starts [5] when the epithelial integrity is 
broken (trauma, surgery, ocular surface disease) and 
the fungus gains access into the corneal tissue. The 
fungus then releases proteolytic enzymes, toxins, 
and fungal antigens that result in corneal tissue ne-
crosis and damage to the corneal architecture, com-
promising in this way the integrity and function of 
the entire eye. 
The early diagnosis [6] of a fungal keratitis plays 
an essential role in the final outcome of the infected 
eye. Corneal ulcers [6, 7] that are unresponsive to 
broad-spectrum antibiotics, the presence of satellite 
lesions, and scanty secretions are some signs that 
should raise suspicion for the possibility of a fungal 
infection. Some of the symptoms of fungal keratitis 
are blurry vision, tearing, foreign body sensation, red-
ness, photophobia, pain, and secretions. On the slit 
lamp [7] examination, the size and depth of the lesion 
should be assessed. If vitreous reaction is observed, 
then this is a sign of intraocular spread of the disease. 
With some kinds of fungi (filamentary fungi), the 
corneal lesion might have a white/greyish infiltrate 
with feathery borders. There might also be satellite 
lesions with hypopyon and conjunctival injection as 
well as purulent secretions. Other types [7] of fungi 
(yeast) cause plaque-like and a little more defined 
corneal ulcers, similar to bacterial infections. The 
above symptoms, combined with a history of trauma, 
especially from vegetable matter, strongly suggest the 
possibility of a fungal infection. In order to confirm 
the suspicion of fungal keratitis, a sample should be 
taken from deep inside the lesion and sent for culture 
and polymerase chain reaction (PCR) examination. 
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The management of fungal keratitis consists of 
the use of topical and/or systemic anti-fungal med-
ication depending on the severity of the case. In 
severe cases surgical treatment [8, 9] may be needed 
(conjunctival flap, therapeutic lamellar, or penetrat-
ing keratoplasty). The difficulty in treating fungal 
keratitis is mostly because of the delay of diagno-
sis. Anti-fungal medication [10–12] available for 
ocular therapy (mainly natamycin 5%) has limited 
penetrating ability into the cornea, which makes the 
effect of the drug a little slow. In severe cases, intra-
venous medication may be preferred. Voriconazole 
[10–12] orally or injected into the corneal stroma 
can be used, as well as oral posaconazole, which is 
a new-generation triazole. Unfortunately, the prog-
nosis of fungal keratitis is not very good. Severe 
visual acuity loss occurs in 26–63% of the patients, 
15–20% need evisceration, and 31–38% of the pa-
tients proceed to penetrating keratoplasty [2, 4].
Patients diagnosed with fungal keratitis should 
be monitored daily, until a sign of improvement 
occurs. Corneal healing might take weeks or 
months. If, despite all the efforts for conservative 
treatment, a surgical approach is inevitable, the an-
timycotic medication [10–12] (topical and oral) 
should continue for at least two weeks postopera-
tively.
CASE REPORT
A female, 72 years old, visited the clinic with 
a severe infection on her left eye. Her eyelid was 
swollen, the eye was red and painful, and visual 
acuity was finger counting (FC) at 30 cm distance. 
The patient had undergone cataract surgery some 
years earlier. The patient had a Descemet Stripping 
Automated Endothelial Keratoplasty (DSAEK) 
due to Fuchs’ dystrophy that had deteriorated after 
cataract surgery, one month ago. The patient was 
on natamycin 5% five times per day, on topical 
voriconazole every two hours, and fluorometholone 
three times daily. 
On a slit lamp examination performed by Dr 
Mallias, a corneal ulcer was observed with whitish 
infiltrates, and the epithelium was not intact (Fig. 1).
There was a strong clinical suspicion that the 
cornea was infected by atypical mycobacteria. This 
was the reason why we performed PCR examination 
both for fungi and atypical mycobacteria. Scrapings 
were taken from deep inside the ulcer and sent for 
a Polymerase Chain Reaction (PCR) examination in 
order to identify the cause of infection. The patient 
was instructed to come back for follow up examina-
tion two days later, along with the PCR results. The 
patient was instructed to discontinue steroid drops 
because it might impair the host cornea natural 
immune reaction. Because there was a high clinical 
suspicion for atypical mycobacteria, the patient was 
instructed to instil moxifloxacin (Vigamox) every 
hour and cyclopentolate hydrochloride two times 
per day in order to reduce ciliary spasm. The results 
of PCR were negative for atypical mycobacteria and 
positive for fungi.
The patient came for a follow-up visit, and the 
clinical image of the corneal ulcer was better (Fig. 2). 
It seemed like the discontinuation of steroid drops 
along with the initiation of moxifloxacin improved 
the situation of the infected cornea. Her visual acuity 
was still FC at 30 cm and she was still in pain.
The PCR results were positive for a fungal infec-
tion, so the treatment was altered accordingly. Mox-
ifloxacin and natamycin 5% were prescribed every 
FIgURE 1. Slit lamp picture from the first visit of the patient. A corneal ulcer is observed with white infiltrates. Also, there is an epithelial defect
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hour and cyclopentolate hydrochloride two times 
daily. The patient was asked to return for a follow 
up examination four days later.
The patient came for the scheduled follow-up. 
The pain on her left eye was slightly better, but the 
lid was still swollen and her eye was still very irritat-
ed, probably due to irritation caused by the antifun-
gal medication. However, the clinical image of the 
corneal ulcer was improved (Fig. 3). The epithelium 
was almost healed and there was still inflammation, 
but the whitish infiltrates had started to fade, which 
is a sign of the eradication of the fungal infection.
The treatment was again slightly altered, adding 
oral voriconazole (200 mg) two times daily. The 
patient was asked to come back in 10 days.
When the patient came back 10 days later, the 
clinical image of the cornea was improved and her 
visual acuity was improved as well (FC at 1.5 m). 
On the slit lamp image (Fig. 4) the improvement is 
obvious because the haziness of the cornea is signif-
icantly improved.
The patient was then advised to come back 
10 days later.
FIgURE 2. Slit lamp photo of the left eye of the patient 3 days after the change of treatment. The epithelium is significantly improved 
since the previous visit
FIgURE 3. Slit lamp photo of the left eye of the patient after the change of treatment, adding anti-fungal medication
FIgURE 4. Significantly improved image of the infected eye of 
the patient, 15 days after treatment initiation
On the patient’s fifth visit, almost a month after 
treatment initiation, the cornea was significantly 
improved. The infiltrates were completely resolved, 
which means the fungus was completely eradicated 
and the epithelium was completely healed. A mild 
haze was observed where the ulcer used to be (Fig. 5). 
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The pain was eradicated, and the patient only felt 
a little discomfort when instilling the drops. 
The visual acuity remained FC at 1.5 m, as 
in the last visit. The treatment was kept the same 
and the patient was asked to come for a follow-up 
10 days later.
After 10 days, the clinical image on the slit lamp 
was even more improved (Fig. 6). The haze had im-
proved and the visual acuity was 20/200.
DISCUSSION
As described in the literature, fungal infection 
after a DSAEK surgery is quite a common com-
plication [13]. There are several studies [14, 15] 
indicating that it is possible for a patient undergoing 
DSAEK surgery to present with fungal interface 
keratitis due to pre-existing donor infection. For 
that reason, these studies suggest that donor corneal 
rim cultures should be prophylactically performed 
in all cases, and confocal microscopy on cases with 
new interface opacities in the early postoperative pe-
riod, in order to start the tissue recipient on antifun-
FIgURE 5. Slit lamp photo from the fifth visit of the patient, 25 days after treatment initiation.
FIgURE 6. Slit lamp photo showing the improvement of the cornea, a full month after treatment initiation
gal therapy as soon as possible. Another study [16] 
indicates that the fungi can penetrate an eye that has 
undergone a second DSAEK (due to primary graft 
failure) through the corneal venting incisions that 
were reopened for the second surgery. 
Also, there are studies [17] that present the man-
agement of late onset fungal keratitis in patients 
that have undergone DSAEK. The two patients in 
this study did not want to undergo further surgery 
in order to deal with the fungal infection, and top-
ical and oral therapy had already failed. These pa-
tients received three to four intrastromal injections 
with antifungal medication, and it was proven to be 
effective in treating late-onset fugal keratitis. 
In the case presented above, it could not be as-
sertained if the fungal infection was due to previous 
donor infection or the recipient patient was contam-
inated during or after the surgery. The symptoms 
started about 20 days after the DSAEK surgery, and 
the patient informed us that she was occupied with 
agricultural activities during this time, which makes 
it possible that the infection started postoperatively. 
However, we have no knowledge if donor corneal 
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rim cultures were made, because we did not perform 
the operation.
Fortunately, the patient responded very well 
to the cortisone discontinuation and to the con-
servative oral and topical treatment, without any 
rejection outbreaks. The cornea cleared from the 
ulcer and the haze almost completely and the visual 
acuity improved as well. If despite our efforts, oral 
and topical treatment had been inadequate and the 
infection had spread to the anterior chamber, our 
first choice would have been intrastromal injec-
tions with antifungal medication. If the injections 
had not provided any positive outcome, then the 
solution would have to have been surgical, with 
a penetrating keratoplasty. 
The take home message is to discontinue steroid 
drops until the complete eradication of the mi-
cro-organism. Our experience is that steroid drops 
should not be re-introduced, at least for one month.
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